Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity

被引：3
|
作者：
Luscher, Thomas F. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Imperial Coll, Cardiol, London, England
[2] Royal Brompton Hosp, Res Educ & Dev, London, England
[3] Harefield Hosp London, London, England
[4] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[5] Zurich Heart House, EHJ Editorial Off, Hottingerst 14, CH-8032 Zurich, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 19期
关键词：
ORAL ANTICOAGULANTS; MANAGEMENT; STROKE; EVENTS;
D O I：
10.1093/eurheartj/ehz302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1477 / 1481
页数：5
相关论文
共 33 条
  • [21] Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities
    Essien, Utibe R.
    Kim, Nadejda
    Magnani, Jared W.
    Good, Chester B.
    Litam, Terrence M. A.
    Hausmann, Leslie R. M.
    Mor, Maria K.
    Gellad, Walid F.
    Fine, Michael J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (02): : 139 - 150
  • [22] Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation A retrospective, observational study
    Chen, I-Chih
    Chang, Wei-Ting
    Hsu, Po-Chao
    Yeh, Ya-Lan
    Zheng, Syuan
    Huang, Yuan-Chi
    Lin, Chih-Hsien
    Tsai, Liang-Miin
    Lin, Li-Jen
    Liu, Ping-Yen
    Liu, Yen-Wen
    MEDICINE, 2021, 100 (23) : E26272
  • [23] Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation
    Chiou, Wei-Ru
    Su, Min-, I
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Liu, Cheng-Wei
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [24] Temporal trends of prescription rates, oral anticoagulants dose, clinical outcomes, and factors associated with non-anticoagulation in patients with incident atrial fibrillation
    Liao, Jo-Nan
    Chan, Yi-Hsin
    Kuo, Ling
    Tsai, Chuan-Tsai
    Liu, Chih-Min
    Chen, Tzeng-Ji
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    Chao, Tze-Fan
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2025, : 300 - 311
  • [25] Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation
    Jelonek, Olga
    Gorczyca, Iwona
    Baczek, Michal
    Kosmider, Pawel
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2018, 76 (07) : 1073 - 1080
  • [26] Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
    Shimizu, Wataru
    Uchiyama, Shinichiro
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    Kitazono, Takanari
    Yamashita, Takeshi
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Shimokawa, Hiroaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 391
  • [27] Benefits and Harms of Standard Versus Reduced-Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation
    Hayes, Kaleen N.
    Zhang, Tingting
    Kim, Dae Hyun
    Daiello, Lori A.
    Lee, Yoojin
    Kiel, Douglas P.
    Berry, Sarah D.
    Zullo, Andrew R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (21):
  • [28] Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
    Lip, Gregory Y. H.
    Nikorowitsch, Julius
    Sehner, Susanne
    Becher, Nina
    Bertaglia, Emanuele
    Blomstrom-Lundqvist, Carina
    Brandes, Axel
    Beuger, Vincent
    Calvert, Melanie
    Camm, A. John
    Chlouverakis, Gregory
    Dan, Gheorghe-Andrei
    Dichtl, Wolfgang
    Diener, Hans Christoph
    Fierenz, Alexander
    Goette, Andreas
    de Groot, Joris R.
    Hermans, Astrid
    Lubinski, Andrzej
    Marijon, Eloi
    Merkely, Bela
    Mont, Lluis
    Ozga, Ann-Kathrin
    Rajappan, Kim
    Sarkozy, Andrea
    Scherr, Daniel
    Schnabel, Renate B.
    Schotten, Ulrich
    Simantirakis, Emmanuel
    Toennis, Tobias
    Vardas, Panos
    Wichterle, Dan
    Zapf, Antonia
    Kirchhof, Paulus
    EUROPEAN HEART JOURNAL, 2024, 45 (19) : 1733 - 1737
  • [29] Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
    Steinberg, Benjamin A.
    Shrader, Peter
    Pieper, Karen
    Thomas, Laine
    Allen, Larry A.
    Ansell, Jack
    Chan, Paul S.
    Ezekowitz, Michael D.
    Fonarow, Gregg C.
    Freeman, James V.
    Gersh, Bernard J.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Naccarelli, Gerald V.
    Reiffel, James A.
    Singer, Daniel E.
    Peterson, Eric D.
    Piccini, Jonathan P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (04):
  • [30] Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
    Hijazi, Ziad
    Oldgren, Jonas
    Lindback, Johan
    Alexander, John H.
    Alings, Marco
    De Caterina, Raffaele
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Held, Claes
    Huber, Kurt
    Hylek, Elaine M.
    Granger, Christopher B.
    Lopes, Renato D.
    Vinereanu, Dragos
    Siegbahn, Agneta
    Wallentin, Lars
    JAMA NETWORK OPEN, 2020, 3 (09)
1234